Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.83
0.14 (8.28%)
At close: Jun 06, 2025, 3:59 PM
1.83
0.00%
After-hours: Jun 06, 2025, 05:46 PM EDT
8.28% (1D)
| Bid | 1.82 |
| Market Cap | 57.09M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -45.51M |
| EPS (ttm) | -1.47 |
| PE Ratio (ttm) | -1.24 |
| Forward PE | -1.8 |
| Analyst | Buy |
| Ask | 1.86 |
| Volume | 323,123 |
| Avg. Volume (20D) | 650,009 |
| Open | 1.69 |
| Previous Close | 1.69 |
| Day's Range | 1.65 - 1.85 |
| 52-Week Range | 1.03 - 8.64 |
| Beta | -0.30 |
About ATNM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATNM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATNM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+18.35%
Actinium Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
2 months ago
+16.53%
Actinium Pharmaceuticals shares are trading higher after the company announced it entered a research collaboration with Memorial Sloan Kettering for clinical expansion of Actimab-A's backbone therapy strategy.
